Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report?

Core Viewpoint - Amphastar Pharmaceuticals (AMPH) has a strong history of beating earnings estimates and is well-positioned for continued success in upcoming quarterly reports [1][2]. Earnings Performance - Amphastar has surpassed earnings estimates by an average of 27.79% over the last two quarters [1]. - In the most recent quarter, the company reported earnings of $0.94 per share, exceeding the expected $0.78 per share by 20.51% [1]. - For the previous quarter, Amphastar's earnings of $1.04 per share surpassed the consensus estimate of $0.77 per share by 35.06% [1]. Earnings Estimates and Predictions - There has been a favorable change in earnings estimates for Amphastar, with a positive Zacks Earnings ESP (Expected Surprise Prediction) indicating potential for another earnings beat [2]. - Stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of producing a positive surprise [2]. Earnings ESP Metric - Amphastar currently has an Earnings ESP of +10.35%, suggesting that analysts have recently become more optimistic about the company's earnings prospects [3]. - The Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions [3]. Importance of Earnings ESP - The Earnings ESP is a crucial metric for predicting earnings performance, as it helps identify stocks likely to beat consensus estimates [4].